Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furfaro

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 11, 2012
Galactomannan: testing the same sample twice?E Furfaro, M Mikulska, F Miletich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 13, 2016
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' responseD R Giacobbe, C Viscoli, E Furfaro, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 2006
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxisM Machetti, M J Majabo, E Furfaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 4, 2016
Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosisM Mikulska, D R Giacobbe, E Furfaro, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2012
Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assayM Mikulska, E Furfaro, V Del Bono, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patientsE Furfaro, M Mikulska, V Del Bono, et al.
Clinical and Vaccine Immunology : CVI|January 21, 2011
Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipientsM Mikulska, E Furfaro, V Del Bono, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 17, 2010
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantationE Castagnola, E Furfaro, I Caviglia, et al.
Bone Marrow Transplantation|March 25, 2009
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patientsM Mikulska, A M Raiola, B Bruno, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 14, 2015
Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and BrazilD R Giacobbe, P Esteves, P Bruzzi, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 11, 2012
Galactomannan: testing the same sample twice?E Furfaro, M Mikulska, F Miletich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 13, 2016
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' responseD R Giacobbe, C Viscoli, E Furfaro, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 2006
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxisM Machetti, M J Majabo, E Furfaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 4, 2016
Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosisM Mikulska, D R Giacobbe, E Furfaro, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2012
Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assayM Mikulska, E Furfaro, V Del Bono, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patientsE Furfaro, M Mikulska, V Del Bono, et al.
Clinical and Vaccine Immunology : CVI|January 21, 2011
Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipientsM Mikulska, E Furfaro, V Del Bono, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 17, 2010
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantationE Castagnola, E Furfaro, I Caviglia, et al.
Bone Marrow Transplantation|March 25, 2009
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patientsM Mikulska, A M Raiola, B Bruno, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 14, 2015
Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and BrazilD R Giacobbe, P Esteves, P Bruzzi, et al.
Pageof 11